Evidence map›Paper›PMID 30004845›Full record

ArticleOmics : a journal of integrative biology2018

A Systems Biology Approach to Understanding the Pathophysiology of High-Grade Serous Ovarian Cancer: Focus on Iron and Fatty Acid Metabolism.

Anna Konstorum, Miranda L Lynch, Suzy V Torti, Frank M Torti, Reinhard C Laubenbacher

Open access · bronzeAbstract read
In one paragraph

Article in Omics : a journal of integrative biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Iron and Cancer: 2020 Vision.Cancer research · 2020
    Review
  4. Iron: The cancer connection.Molecular aspects of medicine · 2020
    Review
  5. Systems biology of ferroptosis: A modeling approach.Journal of theoretical biology · 2020
    Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Anna Konstorum1 Center for Quantitative Medicine, UConn Health , Farmington, Connecticut.
Miranda L Lynch2 Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center , Buffalo, New York.
Suzy V Torti3 Department of Molecular Biology and Biophysics, UConn Health , Farmington, Connecticut.
Frank M Torti3 Department of Molecular Biology and Biophysics, UConn Health , Farmington, Connecticut.
Reinhard C Laubenbacher1 Center for Quantitative Medicine, UConn Health , Farmington, Connecticut.
UConn Health · USJackson Laboratory · USRoswell Park Comprehensive Cancer Center · US

Funding

Iron, Ferroptosis and Ovarian CancerR01CA188025 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI TORTI, SUZY V · 2014 to 2024
$3.9M
Ferroportin and Iron HomeostasisR01CA171101 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI TORTI, FRANK M. · 2012 to 2016
$1.7M
Multiscale modeling of synergistic T cell activation for cancer immunotherapyF32CA214030 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI KONSTORUM, ANNA · 2017 to 2018
$116k
NCI NIH HHS F32 CA214030NCI NIH HHS R01 CA171101NCI NIH HHS R01 CA188025
6 · The paper itself

Abstract

Ovarian cancer (OVC) is the most lethal of the gynecological malignancies, with diagnosis often occurring during advanced stages of the disease. Moreover, a majority of cases become refractory to chemotherapeutic approaches. Therefore, it is important to improve our understanding of the molecular dependencies underlying the disease to identify novel diagnostic and precision therapeutics for OVC. Cancer cells are known to sequester iron, which can potentiate cancer progression through mechanisms that have not yet been completely elucidated. We developed an algorithm to identify novel links between iron and pathways implicated in high-grade serous ovarian cancer (HGSOC), the most common and deadliest subtype of OVC, using microarray gene expression data from both clinical sources and an experimental model. Using our approach, we identified several links between fatty acid (FA) and iron metabolism, and subsequently developed a network for iron involvement in FA metabolism in HGSOC. FA import and synthesis pathways are upregulated in HGSOC and other cancers, but a link between these processes and iron-related genes has not yet been identified. We used the network to derive hypotheses of specific mechanisms by which iron and iron-related genes impact and interact with FA metabolic pathways to promote tumorigenesis. These results suggest a novel mechanism by which iron sequestration by cancer cells can potentiate cancer progression, and may provide novel targets for use in diagnosis and/or treatment of HGSOC.

Indexed as

Fatty AcidsFemaleHumansIronOvarian NeoplasmsSystems BiologyFatty AcidsIronfatty acid metabolismironmicroarraysovarian cancer

Identifiers

PMID30004845
PMCPMC6059353
OpenAlexW2883408148

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.